Understanding Gender Differences in IBS: The Role of Stress From the Social Environment

Jeffrey Lackner, PsyD  P506 Understanding Gender Differences in IBS: The Role of Stress From the Social Environment Author insight from Jeffrey Lackner, PsyD, University at Buffalo, SUNY, Buffalo, NY What’s new here and important for clinicians? IBS ...

Two Years on Linaclotide: Tolerability and Treatment Satisfaction in IBS-C Patients With and Without Diarrhea

P1111 Two Years on Linaclotide: Tolerability and Treatment Satisfaction in IBS-C Patients With and Without Diarrhea William D. Chey, MD, FACG Author insight from William D. Chey, MD, FACG, University of Michigan, Ann Arbor, MI What’s new here ...

Analysis of Exhaled Volatile Organic Compounds Reveals New Biomarkers for Irritable Bowel Syndrome

Oral 12 Analysis of Exhaled Volatile Organic Compounds Reveals New Biomarkers for Irritable Bowel Syndrome Sophia Ali Patel, MD Author insight from Sophia Ali Patel, MD, Pediatric GI, Cleveland Clinic Children’s, Cleveland, OH What’s ...

What Strategies Do Patients With Irritable Bowel Syndrome Continue to Use Following a 9-Week Comprehensive Self-Management Program?

P 1107 What Strategies Do Patients With Irritable Bowel Syndrome Continue to Use Following a 9-Week Comprehensive Self-Management Program? Jasmine Zia, MD Author insight from Jasmine Zia, MD, University of Washington, Seattle, WA What’s new ...

Regional Variation of Care for Irritable Bowel Syndrome in the United States

P1719 Regional Variation of Care for Irritable Bowel Syndrome in the United States Brian E. Lacy, MD, PhD, FACG Author insight from Brian E. Lacy, MD,  PhD, FACG, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire What’s new here ...

Cognitive Behavioral Self-Help for Irritable Bowel Syndrome

P1110 Cognitive Behavioral Self-Help for Irritable Bowel Syndrome Melissa Hunt, PhD Author insight from Melissa G. Hunt, PhD, University of Pennsylvania, Philadelphia, PA What’s new here and important for clinicians? Clinicians need to know ...